Biomarkers or Biological markers are tools that for their availability, economy, specificity and sensitivity are useful in the diagnosis, prognosis and monitoring of canine and feline patients with cardiovascular alterations; widely used and standardized in human cardiology, presented as an excellent complement, of easy access, for specialized tests such as Doppler ultrasound and electrocardiography that, sometimes, are not available in everyday clinical practice. The cardiac troponins are sensitive and specific biomarkers in the detection of different abnormalities that affect the integrity of the myocardium, these are minimally invasive tests, inexpensive and would provide valuable information in the treatment of cardiac patients; therefo...
The measurement of cardiac troponins (cTn) is recommended by all guidelines as the gold standard for...
Cardiovascular diseases are leading cause of morbidity in the world. Measurement of the level of bio...
The release of cardiomyocyte components, i.e. biomarkers, into the bloodstream in higher than usual ...
Analysis of cardiac troponin I (cTn I) and T (cTnT) are considered the “gold standard&...
The cardiac troponins are integral components of the myofibrillary apparatus and they regulate muscl...
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Trop...
A timely and efficient diagnosis is critical in patients with chest pain, to optimize the efficacy o...
A biomarker is an indicator of a normal or pathologic process, or a pharmacologic response to a ther...
diagnosis of cardiac injury is necessary to limitthe extent of myocardial damage and to prevent and ...
Cardiac diseases are mainly caused by malfunction of or injuries to the hearts. Although significan...
Over the past decade, there has been a progressive evolution of cardiac marker testing in patients w...
Testing for the diagnosis of acute myocardial infarction and other diseases included in the spectrum...
Today, the increase of the blood concentration of cardiac troponins is designated as surrogate for c...
AbstractThe diagnosis of myocardial necrosis due to acute myocardial infarction (AMI) and other caus...
The diagnosis of myocardial infarction (MI) depends on a rise and/or fall of cardiac biomarkers such...
The measurement of cardiac troponins (cTn) is recommended by all guidelines as the gold standard for...
Cardiovascular diseases are leading cause of morbidity in the world. Measurement of the level of bio...
The release of cardiomyocyte components, i.e. biomarkers, into the bloodstream in higher than usual ...
Analysis of cardiac troponin I (cTn I) and T (cTnT) are considered the “gold standard&...
The cardiac troponins are integral components of the myofibrillary apparatus and they regulate muscl...
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Trop...
A timely and efficient diagnosis is critical in patients with chest pain, to optimize the efficacy o...
A biomarker is an indicator of a normal or pathologic process, or a pharmacologic response to a ther...
diagnosis of cardiac injury is necessary to limitthe extent of myocardial damage and to prevent and ...
Cardiac diseases are mainly caused by malfunction of or injuries to the hearts. Although significan...
Over the past decade, there has been a progressive evolution of cardiac marker testing in patients w...
Testing for the diagnosis of acute myocardial infarction and other diseases included in the spectrum...
Today, the increase of the blood concentration of cardiac troponins is designated as surrogate for c...
AbstractThe diagnosis of myocardial necrosis due to acute myocardial infarction (AMI) and other caus...
The diagnosis of myocardial infarction (MI) depends on a rise and/or fall of cardiac biomarkers such...
The measurement of cardiac troponins (cTn) is recommended by all guidelines as the gold standard for...
Cardiovascular diseases are leading cause of morbidity in the world. Measurement of the level of bio...
The release of cardiomyocyte components, i.e. biomarkers, into the bloodstream in higher than usual ...